The Director of CIGB and the creator of the Hebreprop P product arrived in Kuwait
Kuwait, March 5, 2017. A delegation headed by Dr. Eulogio Pimentel Vázquez, director of the Center for Genetic Engineering and Biotechnology of Cuba (CIGB), and composed of Dr. Jorge Berlanga, leader of the group of researchers who developed the The main product of exports of Cuban biotechnology, Heberprot-P and engineer Miriela Gil Mena, CIGB commercial officer of CIGB arrived in this capital to participate in the official lunch in Kuwait of Heberprot-P, a new and unique medicine prescribed for the therapy of Diabetic foot ulcer.
Were at the International Airport to receive the Cuban delegation, Andrés González Garrido, Cuban ambassador to Kuwait, Dr. Atef Ramadan Mostafa Ali, Medical Director of the Gulf Medical Company, which is in charge of the distribution and g of Heberprot-P in Kuwait.
Since the end of February has also been in Kuwait Dr. José Ignacio Fernández Montequín fom the Institute of Angiology and Vascular Surgery of Cuba, for the lunch of the Heberprot-P, which is celebrated this March 6.
This new Cuban product was officially registered in Kuwait last January by the authorities of the Ministry of Health.